Emily Aringo
About Emily Aringo
Emily Aringo is a Senior Regulatory Operations Associate at Aimmune Therapeutics, where she has worked since 2017. She has extensive experience in regulatory operations and quality assurance, having held various positions at Medivation and Genentech.
Work at Aimmune Therapeutics
Emily Aringo has been employed at Aimmune Therapeutics since 2017, serving as a Senior Regulatory Operations Associate. In this role, she is involved in regulatory activities that support the development and approval of therapeutic products. Her position is based in San Bruno, California, where she has contributed to the company's regulatory compliance efforts for over seven years.
Experience at Medivation
Emily Aringo has extensive experience at Medivation, where she has worked in various roles since 2009. She began as a Regulatory Operations Associate I and progressed to Senior Regulatory Operations Associate from 2011 to 2014. Currently, she holds the position of Regulatory Operations Manager, having served in this capacity since 2014. Her work at Medivation has spanned a total of ten years, primarily based in San Francisco, California.
Previous Role at Genentech
Before her tenure at Medivation, Emily Aringo worked at Genentech as a Quality Assurance Specialist for one year, from 2008 to 2009. This role provided her with foundational experience in quality assurance processes within the biotechnology sector, contributing to her regulatory expertise.
Education and Expertise
Emily Aringo studied at San Francisco State University, where she completed her education from 2001 to 2006. She furthered her studies at the same institution from 2009 to 2011. Her academic background has equipped her with the knowledge and skills necessary for her roles in regulatory operations and quality assurance within the biotechnology industry.